Patient-No-32-with-Sezary-syndrome-SS-a-before-and-b-after-treatment-with.ppm

Patient No. 32 with Sézary syndrome (SS) (a) before and (b) after treatment with bexarotene. The patient is now on maintenance treatment with 75 mg/day (stable disease). This patient was initially treated for ultraviolet B (UVB)-photosensitivity (and actinic reticuloid), which still persists in the neck and face area. | Ten-year Experience of Bexarotene Therapy for Cutaneous T-cell Lymphoma in Finland – Scientific Figure on ResearchGate. Available from: https://www.researchgate.net/figure/Patient-No-32-with-Sezary-syndrome-SS-a-before-and-b-after-treatment-with_fig4_225283518 [accessed 3 Feb, 2020]

Leave a Reply